Monte Rosa Therapeutics
GLUE
GLUE
104 hedge funds and large institutions have $423M invested in Monte Rosa Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 11 closing their positions.
Holders
104
Holders Change
+23
Holders Change %
+28.4%
% of All Funds
1.39%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
34
Increased
36
Reduced
17
Closed
11
Calls
$2.21M
Puts
$162K
Net Calls
+$2.05M
Net Calls Change
+$1.32M
Top Buyers
1 |
VVM
1
Versant Venture Management
San Francisco,
California
|
$39.2M |
2 |
BI
2
BVF Inc
San Francisco,
California
|
$19.2M |
3 |
3
Morgan Stanley
New York
|
$15.7M |
4 |
4
BlackRock
New York
|
$26.7M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$21.9M |